Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionMHC class Ib protein binding

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

9.70e-1216686GO:0023029
GeneOntologyMolecularFunctionMHC class Ib receptor activity

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

3.26e-1119686GO:0032394
GeneOntologyMolecularFunctionMHC protein binding

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

4.38e-0858686GO:0042287
GeneOntologyMolecularFunctionimmune receptor activity

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

8.89e-08165688GO:0140375
GeneOntologyMolecularFunctionmolecular adaptor activity

SYNPO2 LDB1 TBL1Y TNRC6A DAB2 TMF1 TACC1 KIR2DL1 KIR2DL3 KIR2DL4 LMO4 KIR2DS4 KIR3DL1 KIR3DL2 TBL1XR1 TBL1X

9.46e-0613566816GO:0060090
GeneOntologyMolecularFunctionMHC class I receptor activity

KIR2DS5 KIR3DL1 KIR3DS1

2.97e-0518683GO:0032393
GeneOntologyMolecularFunctionRNA polymerase II-specific DNA-binding transcription factor binding

DACT1 LATS1 LDB1 NFATC1 TMF1 PRDM13 TACC1

5.33e-04417687GO:0061629
GeneOntologyMolecularFunctioninhibitory MHC class I receptor activity

KIR2DS5 KIR3DL1

7.38e-0412682GO:0032396
GeneOntologyMolecularFunctionDNA-binding transcription factor binding

DACT1 LATS1 LDB1 NFATC1 TMF1 PRDM13 TACC1 LMO4

7.88e-04582688GO:0140297
GeneOntologyMolecularFunctioncytoskeletal protein binding

SYNPO2 SPATA31A1 SPATA31A3 KIF26B TTLL5 SPATA31A7 OBSCN FHDC1 SPATA31A6 OGG1 SPATA31A5

1.14e-0310996811GO:0008092
GeneOntologyMolecularFunctionactin binding

SYNPO2 SPATA31A1 SPATA31A3 SPATA31A7 FHDC1 SPATA31A6 SPATA31A5

1.20e-03479687GO:0003779
GeneOntologyMolecularFunctionclathrin binding

GAK DAB2 EPN2

1.30e-0363683GO:0030276
GeneOntologyBiologicalProcessimmune response-regulating signaling pathway

UBQLN1 IGHA1 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.29e-086156914GO:0002764
GeneOntologyBiologicalProcessregulation of immune response

UBQLN1 IGHA1 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 SPPL2B KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.31e-0610856915GO:0050776
GeneOntologyBiologicalProcesspositive regulation of nuclear-transcribed mRNA poly(A) tail shortening

TNRC6A TNRC6B TNRC6C

1.27e-0514693GO:0060213
GeneOntologyBiologicalProcessregulation of nuclear-transcribed mRNA poly(A) tail shortening

TNRC6A TNRC6B TNRC6C

1.94e-0516693GO:0060211
GeneOntologyBiologicalProcessnuclear-transcribed mRNA poly(A) tail shortening

TNRC6A TNRC6B TNRC6C

1.82e-0433693GO:0000289
GeneOntologyBiologicalProcesspositive regulation of Wnt signaling pathway

DACT1 DAB2 DLX5 TBL1XR1 TBL1X

1.87e-04158695GO:0030177
GeneOntologyCellularComponentearly endosome membrane

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

7.14e-05212696GO:0031901
GeneOntologyCellularComponentsuper elongation complex

AFF2 AFF4

1.60e-046692GO:0032783
GeneOntologyCellularComponentacrosomal vesicle

SPATA31A1 SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5

5.96e-04206695GO:0001669
MousePhenoneonatal lethality

RAF1 DACT1 GAK LATS1 KIF26B TNRC6B DLX5 TNRC6C LMO4 AFF4

3.84e-057993810MP:0002058
MousePhenoabnormal tricuspid valve cusp morphology

COL18A1 NFATC1

4.30e-054382MP:0010622
Domainig

OBSCN KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.06e-131906613PF00047
DomainImmunoglobulin

OBSCN KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.06e-131906613IPR013151
DomainIg-like_dom

IGHA1 OBSCN KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.89e-095036614IPR007110
DomainIG

OBSCN KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.23e-094216613SM00409
DomainIg_sub

OBSCN KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.23e-094216613IPR003599
DomainIG_LIKE

IGHA1 OBSCN KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2

1.40e-084916613PS50835
DomainIg-like_fold

NFATC1 IGHA1 OBSCN KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.77e-087066615IPR013783
DomainAgo_hook

TNRC6A TNRC6B TNRC6C

4.21e-083663PF10427
DomainTNRC6_PABC-bd

TNRC6A TNRC6B TNRC6C

4.21e-083663IPR032226
DomainArgonaute_hook_dom

TNRC6A TNRC6B TNRC6C

4.21e-083663IPR019486
DomainTNRC6-PABC_bdg

TNRC6A TNRC6B TNRC6C

4.21e-083663PF16608
DomainDUF4599

SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5

6.89e-0812664PF15371
DomainDUF4599

SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5

6.89e-0812664IPR027970
Domain-

NFATC1 OBSCN KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

4.57e-0766366132.60.40.10
DomainUBA-like

LATS1 UBQLN1 TNRC6A TNRC6B TNRC6C

3.07e-0664665IPR009060
DomainLisH

TBL1Y TBL1XR1 TBL1X

3.49e-069663PF08513
DomainM_domain

TNRC6A TNRC6C

1.23e-052662PF12938
DomainGW182_M_dom

TNRC6A TNRC6C

1.23e-052662IPR026805
DomainTF_AF4/FMR2

AFF2 AFF4

7.35e-054662IPR007797
DomainAF-4

AFF2 AFF4

7.35e-054662PF05110
DomainLisH

TBL1Y TBL1XR1 TBL1X

1.30e-0428663SM00667
DomainLisH

TBL1Y TBL1XR1 TBL1X

1.30e-0428663IPR006594
DomainLISH

TBL1Y TBL1XR1 TBL1X

1.30e-0428663PS50896
DomainUBA

LATS1 UBQLN1 TNRC6C

2.77e-0436663PF00627
DomainUBA

LATS1 UBQLN1 TNRC6C

5.03e-0444663IPR015940
DomainUBA

LATS1 UBQLN1 TNRC6C

6.12e-0447663PS50030
DomainG-protein_beta_WD-40_rep

TBL1Y TBL1XR1 TBL1X

3.39e-0385663IPR020472
DomainUBA

UBQLN1 TNRC6C

5.02e-0330662SM00165
PathwayKEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY

RAF1 NFATC1 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2

2.96e-141374912M5669
PathwayKEGG_ANTIGEN_PROCESSING_AND_PRESENTATION

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2

3.58e-13884910M16004
PathwayREACTOME_DAP12_INTERACTIONS

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

2.93e-0854496MM14871
PathwayREACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY

TNRC6A TNRC6B TNRC6C TBL1XR1 TBL1X

7.72e-0832495M27900
PathwayREACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX

TNRC6A TNRC6B TNRC6C TBL1XR1 TBL1X

1.65e-0737495M29790
PathwayKEGG_GRAFT_VERSUS_HOST_DISEASE

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2

2.81e-0741495M13519
PathwayREACTOME_DAP12_INTERACTIONS

KIR2DS2 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DS1

5.07e-0746495M27151
PathwayREACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING

TNRC6A TNRC6B TNRC6C TBL1XR1 TBL1X

5.66e-0747495M29777
PathwayREACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS

TNRC6A TNRC6B TNRC6C

1.37e-067493M46421
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2

TNRC6A TNRC6B TNRC6C TBL1XR1 TBL1X

2.49e-0663495M27862
PathwayREACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION

TNRC6A TNRC6B TNRC6C

3.27e-069493M27810
PathwayREACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION

TNRC6A TNRC6B TNRC6C

3.27e-069493M46436
PathwayREACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS1 KIR3DL1 KIR3DL2

3.85e-06190497M8240
PathwayREACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS

TNRC6A TNRC6B TNRC6C

4.66e-0610493M48013
PathwayREACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

6.88e-06135496MM14781
PathwayREACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION

TNRC6A TNRC6B TNRC6C

1.10e-0513493M46434
PathwayREACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING

TBL1Y TBL1XR1 TBL1X

1.10e-0513493MM15622
PathwayREACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY

TNRC6A TNRC6B TNRC6C

2.59e-0517493M27788
PathwayREACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA

TBL1Y TBL1XR1 TBL1X

3.10e-0518493MM15034
PathwayREACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS

TNRC6A TNRC6B TNRC6C

3.68e-0519493M48238
PathwayREACTOME_CA2_PATHWAY

NFATC1 TNRC6A TNRC6B TNRC6C

6.20e-0562494M27321
PathwayREACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY

TBL1Y TBL1XR1 TBL1X

6.66e-0523493MM14954
PathwayREACTOME_TGFBR3_EXPRESSION

TNRC6A TNRC6B TNRC6C

1.22e-0428493M48253
PathwayREACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS

TNRC6A TNRC6B

1.76e-046492MM15083
PathwayREACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION

TNRC6A TNRC6B TNRC6C

1.82e-0432493M48012
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4

TNRC6A TNRC6B TNRC6C

2.19e-0434493M46422
PathwayREACTOME_ONCOGENE_INDUCED_SENESCENCE

TNRC6A TNRC6B TNRC6C

2.39e-0435493M27190
PathwayREACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX

TBL1XR1 TBL1X

2.46e-047492M27899
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX

TNRC6A TNRC6B TNRC6C

3.83e-0441493M29748
PathwayREACTOME_SIGNALING_BY_TGFBR3

TNRC6A TNRC6B TNRC6C

6.50e-0449493M48250
PathwayREACTOME_CYTOPROTECTION_BY_HMOX1

TBL1Y TBL1XR1 TBL1X

7.74e-0452493MM15684
PathwayREACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME

TBL1XR1 TBL1X

9.01e-0413492M29766
PathwayREACTOME_HDACS_DEACETYLATE_HISTONES

TBL1Y TBL1XR1 TBL1X

9.12e-0455493MM14932
PathwayREACTOME_ADHERENS_JUNCTIONS_INTERACTIONS

TNRC6A TNRC6B TNRC6C

1.06e-0358493M11980
PathwayREACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS

GAK UBQLN1 DAB2 EPN2

1.47e-03142494MM15499
PathwayREACTOME_SIGNALING_BY_NOTCH

TNRC6A TNRC6B TNRC6C TBL1XR1 TBL1X

1.58e-03246495M10189
PathwayREACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS

GAK UBQLN1 DAB2 EPN2

1.59e-03145494M27753
PathwayREACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING

NFATC1 TNRC6A TNRC6B TNRC6C

1.63e-03146494M27288
PathwayREACTOME_RORA_ACTIVATES_GENE_EXPRESSION

TBL1XR1 TBL1X

1.75e-0318492M26942
PathwayKEGG_WNT_SIGNALING_PATHWAY

NFATC1 TBL1Y TBL1XR1 TBL1X

1.84e-03151494M19428
PathwayREACTOME_ADAPTIVE_IMMUNE_SYSTEM

RAF1 NFATC1 KIR2DS2 KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS1 KIR3DL1 KIR3DL2

1.96e-03828499M1058
Pubmed

Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.48e-3114701219875891
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.48e-3114701215896204
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

7.38e-3115701220082646
Pubmed

Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

7.38e-3115701219926642
Pubmed

[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

7.38e-3115701220356536
Pubmed

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

7.38e-3115701220643584
Pubmed

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

7.38e-3115701219326408
Pubmed

Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.95e-3016701219897003
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.95e-3016701219000141
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.95e-3016701220670355
Pubmed

Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.95e-3016701219527230
Pubmed

Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.95e-3016701220652381
Pubmed

Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.95e-3016701218668235
Pubmed

Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.95e-3016701219279038
Pubmed

No association of KIR genes with Behcet's disease.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.95e-3016701217868255
Pubmed

A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.95e-3016701218643961
Pubmed

Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.95e-3016701219309280
Pubmed

Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.95e-3016701220331834
Pubmed

HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.95e-3016701220210919
Pubmed

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.00e-2917701220173792
Pubmed

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.00e-2917701220483367
Pubmed

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.00e-2917701219968064
Pubmed

[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.00e-2917701219218127
Pubmed

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.00e-2917701220878400
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.00e-2917701220650299
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.00e-2917701219450876
Pubmed

Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.00e-2917701219761533
Pubmed

Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.15e-2912701120371502
Pubmed

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

3.00e-2918701219630074
Pubmed

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

3.00e-2918701220519398
Pubmed

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

3.00e-2918701219046302
Pubmed

Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

3.00e-2918701219846535
Pubmed

Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

3.00e-2918701220580654
Pubmed

KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

8.13e-2919701218571006
Pubmed

Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

8.13e-2919701218778326
Pubmed

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

8.13e-2919701220600442
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

8.13e-2919701218848853
Pubmed

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.03e-2820701220193031
Pubmed

[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.48e-2814701119489269
Pubmed

Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

4.73e-2821701219861144
Pubmed

Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS5 KIR3DL1 KIR3DL2

5.57e-2810701012559621
Pubmed

Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.04e-2722701220492596
Pubmed

KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2

1.30e-2715701117498266
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2

4.16e-2716701116403292
Pubmed

[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

6.11e-2711701019664392
Pubmed

Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.18e-2617701119032228
Pubmed

The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2 KIR3DS1

1.18e-2617701120173784
Pubmed

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.18e-2617701119169284
Pubmed

Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2

3.02e-2618701120200544
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

3.02e-2618701120210918
Pubmed

Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.66e-2612701019181658
Pubmed

[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

3.66e-2612701020137308
Pubmed

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.66e-2612701019936734
Pubmed

Immunogenetic characteristics of patients with autoimmune gastritis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

8.24e-2629701220082482
Pubmed

[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.58e-2513701018687225
Pubmed

KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.58e-2513701019934297
Pubmed

Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.58e-2513701019120281
Pubmed

HLA and KIR frequencies in Sicilian Centenarians.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.59e-2520701120426625
Pubmed

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2

3.17e-2597097749980
Pubmed

Alternatively spliced forms of human killer inhibitory receptors.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

3.17e-2597098662091
Pubmed

Multiple sclerosis associates with LILRA3 deletion in Spanish patients.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

5.54e-2514701019421224
Pubmed

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL4 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

5.54e-2514701018945962
Pubmed

Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

1.31e-2435701219683555
Pubmed

Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.66e-2415701019850842
Pubmed

Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.66e-2415701020207982
Pubmed

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.66e-2415701019493232
Pubmed

Natural killer cells and immune surveillance.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.74e-231170918830515
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

6.95e-231270917490516
Pubmed

Human diversity in killer cell inhibitory receptor genes.

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DL2 KIR3DS1

1.78e-2287089430221
Pubmed

NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

1.78e-22870818681957
Pubmed

Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2

9.82e-20770714607943
Pubmed

Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS4

9.82e-20770711169255
Pubmed

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DS1

9.82e-2077079430220
Pubmed

KIR haplotype content at the allele level in 77 Northern Irish families.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DS1

7.85e-19870717200871
Pubmed

A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

7.85e-19870715730517
Pubmed

Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.

KIR2DS2 KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

3.52e-18970718340360
Pubmed

Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.

KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.17e-171070721206914
Pubmed

Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR3DS1

5.34e-17670617882223
Pubmed

Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

3.73e-16770612618911
Pubmed

Expression of a killer cell receptor-like gene in plastic regions of the central nervous system.

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

3.73e-16770615748957
Pubmed

Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis.

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

3.73e-16770626928464
Pubmed

Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population.

KIR2DS2 KIR2DL4 KIR2DS1 KIR2DS3 KIR3DL2 KIR3DS1

4.46e-15970618074414
Pubmed

In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans.

KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

2.86e-14570519410616
Pubmed

Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

2.86e-14570516112031
Pubmed

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.

KIR2DS2 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

2.86e-1457057716543
Pubmed

Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

2.86e-14570518755860
Pubmed

Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4

2.86e-14570510424431
Pubmed

KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1

2.86e-14570527893413
Pubmed

The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.

SPATA31A1 SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5

1.71e-13670520850414
Pubmed

Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.

SPATA31A1 SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5

1.71e-13670525930072
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population.

KIR2DS2 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DS1

1.71e-13670520528243
Pubmed

Distribution of KIR genes in the Czech population.

KIR2DL1 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

3.58e-12970518186800
Pubmed

Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.50e-11470418632158
Pubmed

Polymorphism and domain variability of human killer cell inhibitory receptors.

KIR2DL3 KIR2DL4 KIR3DL1 KIR3DS1

1.50e-1147049059894
Pubmed

High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.

KIR2DL2 KIR2DL3 KIR3DL1 KIR3DS1

1.50e-11470419522772
Pubmed

[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

1.50e-11470418269867
Pubmed

Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

1.50e-11470426542066
Pubmed

Study of the KIR gene profiles and analysis of the phylogenetic relationships of Rajbanshi population of West Bengal, India.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.50e-11470423354323
Pubmed

[Differential expression levels of killer immunoglobin-like receptor genotype in patients with hematological malignancies between high-risk and standard-risk groups].

KIR2DL1 KIR2DL4 KIR3DL1 KIR3DL2

1.50e-11470418718052
Pubmed

KIR gene in ethnic and Mestizo populations from Mexico.

KIR2DL2 KIR2DS1 KIR2DS5 KIR3DS1

7.51e-11570416698429
InteractionKIR2DL2 interactions

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR3DL1 KIR3DS1

1.98e-1213686int:KIR2DL2
InteractionKIR2DS2 interactions

IGHA1 KIR2DS2 KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS5 KIR3DL1

3.44e-1137687int:KIR2DS2
InteractionKIR2DS3 interactions

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS5

5.61e-0920685int:KIR2DS3
InteractionKIR3DL1 interactions

KIR2DS2 KIR2DL1 KIR2DL2 KIR3DL1

8.28e-0813684int:KIR3DL1
InteractionKIR3DP1 interactions

KIR2DS2 KIR2DL1 KIR2DS5

1.47e-074683int:KIR3DP1
InteractionKIR2DL1 interactions

KIR2DL1 KIR2DL2 KIR2DS3 KIR3DL1

2.28e-0628684int:KIR2DL1
InteractionCLTB interactions

RAF1 GAK TNRC6A OBSCN DAB2 TNRC6B EPN2

2.96e-06185687int:CLTB
InteractionNINL interactions

IRS4 LATS1 IGHA1 TTLL5 SIPA1L3 A2ML1 TNRC6A TNRC6B TNRC6C TBL1XR1

2.98e-064586810int:NINL
InteractionAP2B1 interactions

RAF1 GAK SIPA1L3 TNRC6A DAB2 TNRC6B TNRC6C AFF4 EPN2

4.36e-06373689int:AP2B1
InteractionLATS1 interactions

RAF1 SRRM1 COL18A1 LATS1 SIPA1L3 PTPRQ TNRC6A TNRC6B TNRC6C

1.64e-05440689int:LATS1
InteractionKIR2DS5 interactions

KIR2DS2 KIR2DS3 KIR2DS5

1.99e-0516683int:KIR2DS5
InteractionCLTA interactions

RAF1 GAK SIPA1L3 TNRC6A DAB2 TNRC6B TNRC6C EPN2

2.33e-05351688int:CLTA
InteractionCEP152 interactions

LATS1 MAPK1IP1L SIPA1L3 A2ML1 TNRC6A TNRC6B

3.13e-05179686int:CEP152
InteractionKIR2DS1 interactions

KIR2DS2 KIR2DS1

6.70e-054682int:KIR2DS1
InteractionKIZ interactions

TNRC6A TNRC6B TNRC6C

1.01e-0427683int:KIZ
InteractionFOXK2 interactions

RAF1 NFATC1 TBL1Y TMF1 TBL1XR1 TBL1X

1.11e-04225686int:FOXK2
InteractionITSN2 interactions

TNRC6A TMF1 TNRC6B TACC1 TNRC6C

1.39e-04147685int:ITSN2
InteractionSEC24B interactions

LATS1 TNRC6A DAB2 TNRC6B TNRC6C TBL1XR1

1.58e-04240686int:SEC24B
InteractionMLANA interactions

RAF1 EPN2

1.67e-046682int:MLANA
InteractionEYA4 interactions

RAF1 LDB1 MAPK1IP1L TNRC6A TNRC6B TNRC6C

1.69e-04243686int:EYA4
InteractionHLA-C interactions

RAF1 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4

1.85e-04353687int:HLA-C
InteractionFAM114A2 interactions

KIR2DL1 KIR2DL2 KIR3DL1 KIR3DL2

1.87e-0484684int:FAM114A2
InteractionBICD1 interactions

SYNPO2 SIPA1L3 TNRC6A TMF1 TNRC6B TNRC6C

1.97e-04250686int:BICD1
InteractionCNGB1 interactions

SRRM1 ABCA4

2.33e-047682int:CNGB1
InteractionLHX4 interactions

UBQLN1 LDB1 LMO4 ZHX1 TBL1X

2.45e-04166685int:LHX4
InteractionMDK interactions

RAF1 TNRC18 UBQLN1 AFF4

2.54e-0491684int:MDK
InteractionCEP85 interactions

RAF1 LATS1 TNRC6A TNRC6B TNRC6C

2.66e-04169685int:CEP85
InteractionMPHOSPH9 interactions

LATS1 TNRC6A TNRC6B TNRC6C

3.00e-0495684int:MPHOSPH9
InteractionHDAC1 interactions

RAF1 DACT1 TNRC18 IRS4 NFATC1 TNRC6A TMF1 TNRC6B LMO4 TBL1XR1 ZHX1 TBL1X

3.00e-0411086812int:HDAC1
InteractionCEP135 interactions

DACT1 TTLL5 SIPA1L3 TNRC6A TNRC6B TNRC6C

3.11e-04272686int:CEP135
Cytoband19q13.4

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

2.76e-2179701219q13.4
CytobandEnsembl 112 genes in cytogenetic band chr9q12

SPATA31A7 SPATA31A5

6.38e-058702chr9q12
Cytoband1p22.3

SYDE2 LMO4

5.19e-04227021p22.3
Cytoband9p13.1

SPATA31A1 SPATA31A3

6.19e-04247029p13.1
CytobandEnsembl 112 genes in cytogenetic band chr1p22

ABCA4 SYDE2 LMO4

1.23e-03137703chr1p22
CytobandEnsembl 112 genes in cytogenetic band chr19q13

SIPA1L3 KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

2.26e-031192707chr19q13
GeneFamilyCD molecules|Killer cell immunoglobulin like receptors

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1

3.78e-28184712620
GeneFamilyADAM metallopeptidase domain containing|CD molecules

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2

5.44e-083944710471
GeneFamilyAtaxins|Trinucleotide repeat containing

TNRC18 TNRC6A TNRC6B TNRC6C

4.87e-0725474775
GeneFamilyAF4/FMR2 family|Super elongation complex

AFF2 AFF4

3.96e-0544721145
GeneFamilyAF4/FMR2 family|Super elongation complex

AFF2 AFF4

2.35e-0494721280
GeneFamilyWD repeat domain containing

DMXL2 TBL1Y TBL1XR1 TBL1X

4.71e-03262474362
CoexpressionKAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS5 KIR3DL1

5.81e-1549689M40909
CoexpressionGSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN

SIPA1L3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS5 KIR3DS1

4.80e-08199688M9885
CoexpressionGSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1

6.28e-07190687M4662
CoexpressionGSE22886_NAIVE_TCELL_VS_NKCELL_DN

DAB2 TACC1 KIR2DL1 KIR2DL4 KIR3DS1 TBL1X

1.28e-05198686M4415
CoexpressionHE_LIM_SUN_FETAL_LUNG_C4_CD16_POS_NK_CELL

KIR2DL1 KIR2DL3 KIR3DL1

1.33e-0518683M45763
CoexpressionHE_LIM_SUN_FETAL_LUNG_C0_MYL4_POS_SMC_CELL

SYNPO2 NFATC1 KIF26B FHDC1 SMTNL2

1.79e-05124685M45673
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000

DACT1 SYNPO2 IRS4 LATS1 KIF26B SIPA1L3 TNRC6C LMO4 TBL1XR1 PCDH18

4.29e-058065610gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000

DACT1 SYNPO2 IRS4 LATS1 NFATC1 KIF26B DAB2 DLX5 TBL1XR1 PCDH18

5.83e-058365610gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000
CoexpressionAtlaskidney_P3_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_500

CDV3 TBL1XR1

6.80e-055562gudmap_kidney_P3_CapMes_Crym_k1_500
ToppCellsevere-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

DAB2 KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

1.61e-081986576ef22f33b43e9adceea11738e3cba0e8b59b4ec6
ToppCellmild-Lymphocytic-NK_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

DAB2 KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

1.61e-08198657dce3c008757786aa6bd4a869456b76b4cbbb1d5b
ToppCellmild-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

DAB2 KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

1.61e-081986571d20fc9948965de52a98f758035edfdd12cafc5f
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2 SMAD5-AS1

2.17e-071756568fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-2|TCGA-Colorectal / Sample_Type by Project: Shred V9

NFATC1 KIR2DL1 KIR2DL4 LMO4 KIR2DS4 KIR3DL2

2.24e-071766561870860a9ebe7a655c4ea8898427e1097ee23113
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

3.11e-07186656e84a0ba599935ca5e7af48e0fb0500e7ed195d55
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

3.11e-071866561590fe72badffc79f1d390deb3207116ac2281bb
ToppCell5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRDM13 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

3.11e-07186656e37e317e9770e35cb41137f51868d8b20ecd21d8
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

3.98e-07194656ae5357e2a276473cde1fc8c43acaf9f69da35fd7
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

3.98e-071946563a0b8b5d0354c43da57bb951cd8ba878363c3de5
ToppCellwk_08-11-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

DACT1 SYNPO2 NFATC1 KIF26B FHDC1 SMTNL2

4.10e-07195656dba2a87efd7e067c094c4b367feb4138cab62735
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD16|lymph-node_spleen / Manually curated celltypes from each tissue

DAB2 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

4.10e-07195656e756733cf48768bf40058d6cf9039e52f7563133
ToppCellBL-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

4.22e-07196656cfbeaabbeeb197f0cf8240a752d1f2995d59d7b7
ToppCellsevere-Lymphocytic-NK_cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

4.35e-071976568bf88b10d49ac499e7d0ba5b7023909e1fd7b29a
ToppCellCOVID-19_Severe-NK_activated|World / disease group, cell group and cell class

IGHA1 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

4.35e-07197656a60db36d1a192998e3ded63e0c7c08d41689f95f
ToppCellnormal_Lymph_Node-T/NK_cells-NK|T/NK_cells / Location, Cell class and cell subclass

KIR2DL1 KIR2DL3 KIR2DL4 LMO4 KIR3DL1 KIR3DL2

4.48e-0719865675e94298bf03d755fef46df685437d0d29fdbca9
ToppCellcontrol-Lymphocytic-NK_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

DAB2 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

4.48e-071986561c779101d0c5f29de5cc7170d784931d6e34bdcd
ToppCellsevere_COVID-19-NK|World / disease group, cell group and cell class (v2)

IGHA1 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

4.48e-0719865636b1370ef68c4bbe0268933a6ef5e6022d992bdf
ToppCell390C-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

DAB2 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

4.48e-07198656623e5ada1a54cd42c32a1519b84dbe782384ee0c
ToppCellcontrol-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

DAB2 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

4.62e-071996568aca7775b3d34fd26c7b23ddb23f5f2df72684b0
ToppCellCaecum-T_cell-gd_T|T_cell / Region, Cell class and subclass

IGHA1 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

4.75e-07200656564117144a3059017a07d66f718b9b5a1f18265b
ToppCell367C-Lymphocytic-NK_cells-NK_cell_C|367C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

3.28e-06156655a1b9e7621b646d354c2ccd850ce6a4fa9ff8a026
ToppCell368C-Lymphocytic-NK_cells|368C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

3.39e-06157655ef5c0ace4cd500b6cc50fb7076298f3d3543b40c
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

4.07e-06163655466c8129852a5b16cd9fcc6b79e799abc21bb21a
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

4.71e-06168655240ea32b64d86f9216785010d6b237d9adf052c9
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

4.71e-06168655b4bb03efb601a61465260f93896c56861c588bef
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

4.85e-06169655e7470a5b060881b2a8ce2ab04b0788396aa13889
ToppCellNS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2

5.14e-06171655adda76991d9b150bb8ccf3989b7cbbf41843cf0b
ToppCell3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue

DAB2 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

5.29e-06172655701de463f85aaad3a4b36a0d5fbc416406620089
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

5.29e-06172655e3a8891694343b6b01e80a200ae338d24797e417
ToppCell10x5'v1-week_17-19-Lymphocytic_NK-T_NK-mature_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

6.08e-061776550f2616a81f8fbede77c860b2126e3fa826672da3
ToppCell10x3'2.3-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

6.59e-061806551c8398342d3fa4d5ca9a8a63626cc497c5291446
ToppCell10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

6.59e-06180655ddbab26b05f057bd78b78773381cd447bd2e2726
ToppCell10x3'2.3-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

6.59e-061806550a98d21fec67a890e75ebf0e2d23adddd77da214
ToppCell367C-Lymphocytic-NK_cells-NK_cell_A|367C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

6.59e-06180655023c83f0c9d0280983c6fd28ecf04bfa6b1b89e2
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

COL18A1 AFF2 OBSCN TACC1 PCDH18

7.73e-06186655888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCellAdult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor

COL18A1 AFF2 OBSCN TACC1 PCDH18

7.93e-0618765562759efb660179402fb574ce5701c89a2e17bcfe
ToppCellFetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

COL18A1 AFF2 OBSCN TACC1 PCDH18

7.93e-06187655a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCellCOPD-Lymphoid-NK|COPD / Disease state, Lineage and Cell class

TNRC6B KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

8.14e-06188655c9a227c8e71b69929d43e9afb8306a95c8163778
ToppCellFetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

COL18A1 AFF2 OBSCN TACC1 PCDH18

8.14e-06188655ccddc08121caff958a2b6f9e278a018858af6b4d
ToppCell10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

8.14e-061886550a2be6eac6fde669fbc58fd1b2e93e4acf17ddde
ToppCellControl-Lymphoid-NK|World / Disease state, Lineage and Cell class

TNRC6B KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

8.35e-0618965589ef0d0e66dc96cacaae6be7aacdaa884e8e66a8
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

DACT1 SYNPO2 KIF26B FHDC1 PCDH18

8.35e-06189655f75cebd4c3e54e297557449ba67ccc8d1a2a14f5
ToppCellMesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor

COL18A1 AFF2 OBSCN TACC1 PCDH18

8.35e-06189655d7ed96add29f219183c802895fbff519b627f635
ToppCellCOPD-Lymphoid-NK|World / Disease state, Lineage and Cell class

TNRC6B KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

8.35e-06189655c0ac160fa7e68b92414fb1600abcac8ad1a42232
ToppCellCOVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

8.35e-06189655b699152dfbb8cd8ed724e1e5a51838f29b681b62
ToppCellmetastatic_Brain-T/NK_cells-NK|metastatic_Brain / Location, Cell class and cell subclass

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

8.57e-0619065550e937ba0600e1ac6215f056bb545dc1e8b28a76
ToppCellSmart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1

8.57e-061906551f890be1ac8613a098b271945f25a58c3c2530ab
ToppCell10x3'2.3-week_14-16-Lymphocytic_NK-T_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

8.57e-0619065567fa7472ec534179087963177351552cc3c335eb
ToppCell3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IGHA1 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1

8.57e-06190655ce049630ed69d31f00acbc1b5b0896efc592121f
ToppCell10x3'2.3-week_14-16-Lymphocytic_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

8.57e-06190655094efcde2b037ae509298abb8b2b1d52f9c86a45
ToppCellSmart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1

8.57e-06190655d7cecf88451f736f8f3f6f4644504cf22846cd6e
ToppCellControl-Lymphoid-NK|Control / Disease state, Lineage and Cell class

TNRC6B KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2

8.57e-06190655f7bd8521a40ac30a64dc439f17e2f6c7d021ef65
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

IGHA1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

8.57e-06190655600b9674197f743dea1d19d3df0fc993b6e6aa25
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|lymph-node_spleen / Manually curated celltypes from each tissue

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

8.79e-06191655f802a4686ecf00e8302047bfe23356f24b266cf8
ToppCellFetal_29-31_weeks-Immune-natural_killer_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

8.79e-061916555696e2e2db7b898a1c7ab3582ae74cb712dd5bdf
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

8.79e-06191655753deb090b7b78b4ef31604dbe5dbfc4dcf5184a
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

COL18A1 AFF2 OBSCN TACC1 PCDH18

8.79e-06191655716dfa7fccbd62b5f574792e68a26dc6c45511dc
ToppCell343B-Lymphocytic-NK_cells-NK_cell_D|343B / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

8.79e-061916552bd4ba4aaa0f4885079516156b409df527ab22f4
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

8.79e-06191655355f5bcb220d917163833dead0050fc756c7b260
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

8.79e-06191655337d7d7b89fe370e1fe005b9daad76c5dc3b8444
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

COL18A1 AFF2 OBSCN TACC1 PCDH18

8.79e-061916551626b23a57429f835fddc052e3c57f63a4e5b8bb
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

IGHA1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.01e-06192655c5f77c2103841505d13e09173549811312ef2f01
ToppCell10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.01e-06192655e48bbcb97c113f323ad4db96bd10d593b9206923
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.01e-061926550cada869e852d4b9a60e95886c927fc24d072364
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

IGHA1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.01e-06192655e981162f387a31111c0ae8355dbe9db5785c4838
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

TNRC6A TNRC6B SCAF11 TACC1 AFF4

9.01e-06192655916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.01e-06192655f1a843e22bdef9fdc063c21f096269eb4af590a8
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.01e-061926551922b0350d3375e67c314dbce8074e5cf986f2ef
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo|lymph-node_spleen / Manually curated celltypes from each tissue

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.01e-061926554d72b9264ed62e0c08cde4078061b348253f6989
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.01e-0619265597c197643e59835c6d45dde9e549c9a1b1bb7288
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.01e-06192655de937cc101a654c6699090beb7e24c430d5a19bf
ToppCellnormal_Pleural_Fluid-T/NK_cells-NK|normal_Pleural_Fluid / Location, Cell class and cell subclass

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.01e-0619265559dd4f5ae9f1cca78adf60b71661092ef09e6641
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.01e-06192655a4d161e3d48bc020e687808b352325ef9d1cc1f3
ToppCellTracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.24e-0619365591a1c9b8390cbd881db8c49d8f34feca0d1067d6
ToppCell3'_v3-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.24e-06193655a98ee519e0da93ae4a2dcdda1ee8b4138dec131b
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

TNRC6A TNRC6B SCAF11 TACC1 AFF4

9.24e-06193655e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCellICU-SEP-Lymphocyte-T_NK-NK|ICU-SEP / Disease, Lineage and Cell Type

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.24e-06193655f110f86db305e41639087f5b1a2dff103c07adf0
ToppCell3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.48e-06194655fa72c2f3e6b8bfc2ef126deb219ec6a44809385b
ToppCell10x5'v1-week_14-16-Lymphocytic_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.48e-061946555a859885c0f9b8554b0d203e371c70928ad4418f
ToppCell10x5'v1-week_14-16-Lymphocytic_NK-T_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.48e-061946557d35ac70ba966eb1fee4197f7de6d6116326a442
ToppCellLeuk-UTI-Lymphocyte-T_NK-NK|Leuk-UTI / Disease, Lineage and Cell Type

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.48e-0619465536afc4e48d267be3b8aa1e33fad043bcd54c6bc5
ToppCell3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.48e-061946557773501e076d470158dbc1d7f10c67152b326eb7
ToppCell367C-Lymphocytic-NK_cells|367C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.48e-061946552e447de50b3f4b59e3b9928df83879955fed93cc
ToppCell10x5'-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.48e-06194655c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e
ToppCellIPF-Stromal-Pericyte|World / Disease state, Lineage and Cell class

COL18A1 SYNPO2 AFF2 DLX5 SMTNL2

9.48e-061946551a41da29d5adaf766a84eff0003b959e4523f7f1
ToppCell3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.48e-06194655bc7c4efe2a82057fb95582da983e36f413990902
ToppCell3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.48e-06194655b43788e458a80ab93f485f4577370aec448ad95e
ToppCell3'_v3-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.48e-061946553337042eef91a49f621058785723228cf4dfdad4
ToppCell343B-Lymphocytic-NK_cells-NK_cell_C|343B / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.48e-06194655fe36cf5cf8ebd761d29ad23ee074128a12d32031
ToppCell10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Liver / Manually curated celltypes from each tissue

CDV3 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.72e-06195655972b09697b7b66fb8a27dfc0c0b05a844121f055
ToppCellmetastatic_Brain-T/NK_cells-NK|T/NK_cells / Location, Cell class and cell subclass

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.72e-06195655184471f71b8bbffec12ebb8dd6a0af589e021c02
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.72e-0619565598b02beafe1d418442e41f85cbf0c7b194fe5957
ToppCell343B-Lymphocytic-NK_cells|343B / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.72e-0619565533a460624a65ba033452c74d143089e0bfac8f3d
ToppCell10x5'-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.72e-06195655e91e7f89163c615b706f3297b641b1e4c966f5e6
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.72e-061956559ecae6c26a0d0607d101ccf1c38f0b23c5a256a8
ToppCellCOVID-19-Lymphoid-CD8_T_cells|Lymphoid / Condition, Lineage and Cell class

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.72e-06195655d4c70a462b98963e78f4e2659574bc350f8ffe1a
ToppCell10x5'-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.72e-06195655a5a10ef9254c266316e5591bec19e159cc3caead
ToppCell10x5'-blood-Lymphocytic_NK|blood / Manually curated celltypes from each tissue

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.72e-06195655c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb
ToppCellBAL-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2

9.96e-0619665564b23d819efddb25024c86f2e1b5dc4159337ddd
ComputationalNeighborhood of IL2RB

KIR2DS2 KIR2DL1 KIR2DS4 KIR3DL1 KIR3DL2

9.79e-0746435GNF2_IL2RB
DrugAa1

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2

4.23e-14836610CID009549188
DrugD-Au

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2

1.13e-1277669CID000277822
Drug6-carboxyfluorescein diacetate

TTLL5 KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL2

2.36e-0830665CID000151095
DrugAC1L1AQK

KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

5.38e-08119667CID000001105
Drugpristane

KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.88e-07152667CID000015979
Drug1xa5

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4

2.94e-0793666CID000157684
DrugAzacitidine

NFATC1 DLX5 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 OGG1 PCDH18

3.09e-074156610ctd:D001374
DrugAb-9

KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2

3.71e-0721664CID006540280
Drugglycoluril

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2

4.52e-0753665CID000062347
Drug1c88

KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

1.76e-06126666CID000444766
Drug(-)-depudecin; Down 200; 1uM; MCF7; HT_HG-U133A_EA

TTLL5 SIPA1L3 TNRC6B DELE1 AFF4 EPN2

2.23e-05196666982_DN
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A

TTLL5 DELE1 OGG1 AFF4 EPN2 TBL1X

2.36e-051986661650_DN
DrugVidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A

COL18A1 LDB1 TTLL5 SPPL2B EPN2 TBL1X

2.43e-051996667203_DN
DrugC2(+)

KIR3DL1 KIR3DL2

2.48e-053662CID006857645
Drugacyclovir

AFF2 KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

3.03e-05124665CID000002022
DrugNSC237521

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4

3.29e-05210666CID000428410
DrugDNTB

KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

3.85e-05216666CID000015325
DrugAGN 1135

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2

5.60e-05141665CID000122316
Drug2-nitro-p-cresol

KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL2

7.06e-0576664CID000008391
DrugAC1ODVCS

KIR2DL2 KIR2DL3 KIR3DL2

8.93e-0530663CID000111104
Drugbunazosin

KIR2DS1 KIR2DS3 KIR2DS4

1.09e-0432663CID000002472
Diseasesensory system disease (implicated_via_orthology)

TBL1Y TBL1XR1 TBL1X

9.28e-093633DOID:0050155 (implicated_via_orthology)
Diseasekiller cell immunoglobulin-like receptor 2DL4 measurement

KIR2DL4 KIR2DS4 KIR3DL2

2.01e-0612633EFO_0008197
Diseasekiller cell immunoglobulin-like receptor 2DS2 measurement

KIR2DL1 KIR2DL3 KIR2DL4

4.14e-0615633EFO_0801746
Diseaselevel of killer cell immunoglobulin-like receptor 2DS2 in blood serum

KIR2DL1 KIR2DL3

1.34e-053632OBA_2042107
Diseaseacquired immunodeficiency syndrome (is_implicated_in)

KIR2DL1 KIR3DS1

1.60e-049632DOID:635 (is_implicated_in)
DiseaseDEAFNESS, AUTOSOMAL RECESSIVE (disorder)

DMXL2 PTPRQ

3.45e-0413632C1846647
DiseaseNoonan-Like Syndrome With Loose Anagen Hair

RAF1 A2ML1

7.49e-0419632C3501846
DiseaseCostello syndrome (disorder)

RAF1 A2ML1

7.49e-0419632C0587248
DiseaseNoonan syndrome-like disorder with loose anagen hair

RAF1 A2ML1

7.49e-0419632C1843181
DiseaseCardio-facio-cutaneous syndrome

RAF1 A2ML1

7.49e-0419632C1275081
DiseaseLEOPARD Syndrome

RAF1 A2ML1

1.01e-0322632C0175704
Diseasemalaria (is_implicated_in)

KIR3DL1 KIR3DS1

1.20e-0324632DOID:12365 (is_implicated_in)
DiseaseNoonan Syndrome

RAF1 A2ML1

1.20e-0324632C0028326
Diseasetype 2 diabetes mellitus (implicated_via_orthology)

IRS4 AFF2 AFF4

1.49e-03105633DOID:9352 (implicated_via_orthology)
DiseaseBone Diseases, Developmental

DLX5 AFF4

1.52e-0327632C0005941
Diseasechronic kidney disease

ABCA4 NFATC1 SIPA1L3 DAB2

1.62e-03235634EFO_0003884
Diseasehepatitis C (is_implicated_in)

KIR3DL1 KIR3DS1

1.64e-0328632DOID:1883 (is_implicated_in)
Diseasetuberculosis (is_implicated_in)

KIR3DL1 KIR3DS1

1.64e-0328632DOID:399 (is_implicated_in)
DiseaseCone-Rod Dystrophy 2

ABCA4 TTLL5

1.76e-0329632C3489532
DiseaseCarcinoma, Ovarian Epithelial

RAF1 SYNPO2

1.88e-0330632C4721610
Diseasecreatinine measurement, glomerular filtration rate

NFATC1 SIPA1L3 DAB2

2.03e-03117633EFO_0004518, EFO_0005208

Protein segments in the cluster

PeptideGeneStartEntry
PLSQTSSKPDPSQWE

TACC1

376

O75410
GNSTPWKTPSVSPNI

ABCA4

1456

P78363
SPWVSNGKNTPSPVS

AFF2

1201

P51816
IYWSQKPTPSSNASP

A2ML1

1171

A8K2U0
TPNSSPAQWPGVSSL

DMXL2

2311

Q8TDJ6
LWSPSSKGTQGATPP

CCDC157

626

Q569K6
NSPQSPAVWEPQGSS

DLX5

216

P56178
KSSGPWNKTAPVQAP

CDV3

136

Q9UKY7
SKWTPVGPAPSTSQS

AFF4

106

Q9UHB7
SPNNLSPTGWSQPKT

RAF1

296

P04049
NSWPSPTEPSSKTGN

KIR2DS2

226

P43631
SSWPSPTEPSSKSGI

KIR3DL2

321

P43630
PPLGTHSSVQPSSKW

PCDH18

1071

Q9HCL0
AGPWPFSSSQTQPAV

DAB2

361

P98082
PNAWSTTSPLGNPFQ

DAB2

581

P98082
GPSQNPPSSTDTVWS

FHDC1

926

Q9C0D6
NSWPSPTEPSSKTGN

KIR2DL2

226

P43627
NSWPSPTEPSSKTGN

KIR2DS4

226

P43632
ANSPWNSKPPSSQES

LDB1

386

Q86U70
NSWPSPTEPSSETGN

KIR2DL3

226

P43628
VPGLQTNWPQSSSAP

LATS1

426

O95835
TNWPQSSSAPAQSSP

LATS1

431

O95835
SSSQPPPVTAGSLSW

LMO4

6

P61968
AEPWGPSASTNQTNP

EPN2

351

O95208
SSSPPGGKHTPWSTQ

KIF26B

1771

Q2KJY2
SSWPSPTEPSSKSGN

KIR3DL1

321

P43629
GPSSTPQENGTTLWP

COL18A1

156

P39060
QTSPWQSPCVSPKTT

NFATC1

201

O95644
NSWPSPTEPSSKTGN

KIR2DS3

226

Q14952
WHPTTSQAKGPSPQT

OGG1

281

O15527
TGNSSNSWPSPTEPS

KIR2DS5

221

Q14953
NSWPSPTEPSSETGN

KIR2DS5

226

Q14953
NASNWISTKTLPGPP

PTPRQ

1566

Q9UMZ3
PTKSSPSRQGWVSPA

OBSCN

5646

Q5VST9
SVTGNPSSSWPSPTE

KIR2DL4

216

Q99706
TTPKGSSSWQTSRPP

GAK

1111

O14976
PSLNNGTFSPPKQWS

DACT1

406

Q9NYF0
TWTPSSGKSAVQGPP

IGHA1

161

P01876
ASSAPSATSPTPGKW

PRDM13

231

Q9H4Q3
SPSTTWSPNKDTPQE

SCAF11

796

Q99590
NSWPSPTEPSSKTGN

KIR2DL1

226

P43626
GSWASTANTVPPTQP

C4orf19

121

Q8IY42
WRVTPKSTSPDGPQT

DELE1

21

Q14154
SNTPAPSTQGLPDSW

IRS4

931

O14654
NSWPSPTEPSSETGN

KIR2DS1

226

Q14954
GSNPWNNPSAPSSVP

MAPK1IP1L

36

Q8NDC0
PNPSPVKKGSSINWS

SYDE2

501

Q5VT97
QADGTWSSPTPKCQP

SUSD2

766

Q9UGT4
PGLTNPKPSSTWGAS

TNRC6C

1476

Q9HCJ0
SPGTSQAKGKPSPWQ

SPATA31A6

626

Q5VVP1
SSWPSPTEPSSKSGN

KIR3DS1

321

Q14943
PGTSQAKGKPSPWQS

SPATA31A7

631

Q8IWB4
NSLPASKWATPTTPG

SIPA1L3

1091

O60292
TIKWSPTGPGTNNPN

TBL1XR1

396

Q9BZK7
STGAPPSSAENWNLP

CLCN1

896

P35523
KWSPTGPATSNPNSN

TBL1X

461

O60907
PGTSQAKGKPSPWQS

SPATA31A3

631

Q5VYP0
WPAQGPSSSKLTPSL

TNRC18

1746

O15417
TQATQTSPGVPWPSQ

UHRF1BP1L

1396

A0JNW5
TWGLKSNTEPQSPPI

TMF1

61

P82094
KSSSSQPVTPVSPVW

SYNPO2

766

Q9UMS6
PGTSQAKGKPSPWQS

SPATA31A1

631

Q5TZJ5
PGTSQAKGKPSPWQS

SPATA31A5

631

Q5VU36
VSNTSRWTAAPPQPG

STPG1

291

Q5TH74
VQSQSPSTNWSPAVP

SRRM1

771

Q8IYB3
PNPWAPQTSQSSSAS

UBQLN1

321

Q9UMX0
ATSPWPAEQSPKSRT

SPPL2B

541

Q8TCT7
TVGTAQPKQSWNPFP

ZHX1

551

Q9UKY1
TPWTPSPSEKNSSFT

SMTNL2

236

Q2TAL5
TIKWSPTGPATSNPN

TBL1Y

406

Q9BQ87
PPPQSSSWSGNIVFT

SMAD5-AS1

16

Q9Y6J3
RAKSPNGSSSVNWPP

TNRC6A

1596

Q8NDV7
SGPTWSTQSDPQAPE

TTLL5

1086

Q6EMB2
VRPSNSSWSSGPQPA

TNRC6B

851

Q9UPQ9
VWSKSTPPAPDNGTS

TNRC6B

936

Q9UPQ9
SEPQSPVAQTSGWPA

NACC1

141

Q96RE7